Brind.

Harrow forecasts growth exceeding the industry average in the pharmaceuticals sector.

1 report, 1 independent Updated Aug 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Harrow forecasts growth exceeding the industry average in the pharmaceuticals sector.

Who's involved

What this event is mainly about
Harrow Borough F.C.

How it developed

Newest first. Tap a step to see who reported it.
  1. Harrow's model is noted to mirror successful rollups seen in companies like Horizon Pharmaceuticals.Sub-event
  2. Harrow forecasts growth exceeding the industry average in the pharmaceuticals sector.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Simply Wall St.Harrow Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag Revenue: US$63.7m (up 30% from 2Q 2024). Net income: US$5.00m (up from US$6.47m loss in 2Q 2024). Profit margin: 7.8% (up fro